| Lyndsey Baughman, | |
|
208 E 7th St, Hays, KS 67601-4139 | |
| (785) 628-2871 | |
| (785) 628-0330 |
| Full Name | Lyndsey Baughman |
|---|---|
| Gender | Female |
| Speciality | Psychologist - Clinical |
| Location | 208 E 7th St, Hays, Kansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356744775 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC0700X | Psychologist - Clinical | T-LMLP 2573 (Kansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Lyndsey Baughman, 208 E 7th St, Hays, KS 67601-4139 Ph: (785) 628-2871 | Lyndsey Baughman, 208 E 7th St, Hays, KS 67601-4139 Ph: (785) 628-2871 |
News Archive
Citing data on how HIV/AIDS has affected children worldwide, whether directly or through the death of one or both parents, U.S. Global AIDS Coordinator Ambassador Eric Goosby, who also heads the State Department's Office of Global Health Diplomacy, writes in the agency's "DipNote" blog that children are vulnerable "to the social, emotional, economic, and environmental effects that HIV and AIDS has on families, communities, and countries."
Medical News Today recently reported that America's pharmaceutical research and biotechnology companies are working on nearly 100 life-changing medicines for diseases affecting people with HIV/AIDS, according to a new report released by the Pharmaceutical Research and Manufacturers of America (PhRMA).
Data from a long-term care facility in the USA indicate that a dedicated palliative care consult service results in a more favorable course of treatment and clinical outcomes for residents.
The National Institutes of Health today announced that Zachary T. Schug, Ph.D., assistant professor in the Molecular & Cellular Oncogenesis Program at The Wistar Institute, was awarded the prestigious NIH Director's New Innovator Award in support of his research on the link between a high sugar/fat diet, alcohol use and cancer.
ISTA Pharmaceuticals, Inc. today announced poster presentations of results from the Company's Bepreve(TM) (bepotastine besilate ophthalmic solution) 1.5% Phase 3 clinical studies in allergic conjunctivitis. The studies demonstrated Bepreve was safe and well-tolerated when given twice daily for six weeks in a healthy pediatric population as young as three years of age.
› Verified 5 days ago
Brandie Bieker, LMLP Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1010 Downing Ave Ste 60, Hays, KS 67601 Phone: 785-621-4417 | |
Mr. Walter B Hill, MS Psychologist Medicare: Not Enrolled in Medicare Practice Location: 208 East 7th St, Hays, KS 67601 Phone: 785-628-2871 Fax: 785-628-1438 | |
Mr. Paul Peter Karlin, LMLP LCP Psychologist Medicare: Not Enrolled in Medicare Practice Location: 208 E 7th, Hays, KS 67601 Phone: 785-628-2871 Fax: 785-628-1248 | |
Eric R Brown, T-LMLP Psychologist Medicare: Not Enrolled in Medicare Practice Location: 323 West 12th Street, Hays, KS 67601 Phone: 785-623-2416 Fax: 785-623-2418 | |
Clayton W. Howard, T-LMLP Psychologist Medicare: Not Enrolled in Medicare Practice Location: 208 E 7th St, Hays, KS 67601 Phone: 785-628-2871 Fax: 785-628-0330 | |
Mr. David Scott Anderson, MS Psychologist Medicare: Not Enrolled in Medicare Practice Location: 208 E 7th, Hays, KS 67601 Phone: 785-628-2871 Fax: 785-628-1438 | |
Ms. Catharine I Shaffer, MS LMLP LCP Psychologist Medicare: Not Enrolled in Medicare Practice Location: 208 E 7th St, Hays, KS 67601 Phone: 785-628-2871 Fax: 785-628-0330 |